Clinical Trials and Behavioral Studies

Our current active protocols are listed below. If you have any questions about the particular study protocol, please contact the study coordinator.  For more information about the research or participation in general, please call our office at 312-695-8643.

Feinberg Clinical Trials

Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.

CoordinatorPIStudy Description
Marko Mihailovic MA, LPC, CCRC
marko.mihailovic( at )northwestern.edu
312-503-9096
Morris Goldman, MD

Study Title: Oxytocin on Cognitive Enhancement Training

Target Population: Adults 18 to 65 years old with psychosis (current patients at the Stone outpatient program).

Aim: To investigate the  impact of intranasal oxytocin on cognitive enhancement training for people with psychosis.

Marko Mihailovic MA, LPC, CCRC
marko.mihailovic( at )northwestern.edu
312-503-9096
Morris Goldman, MD

Study Title: Oxytocin Faces

Target Population: Adults 18 to 65 years old with psychosis.

Aim: To determine whether the hormone oxtyocin influences how patients interpret pictures of people’s faces.

Melody Fairchild, MAT
m-fairchild( at )northwestern.edu
312-503-7071
James Reilly, PhD

Studay Title: Chicago Adolescent Longitudinal Study;

Target Population: Adolescents and young adults (ages 12 to 26 years old) with changes in thoughts, feelings, and behavior OR drug use.

Aim: To understand more about early phases of mental illness.

Sara Rocus, BS
sara.rocus( at )northwestern.edu
312-503-9094
Matthew J. Smith, PhD, MSW, MPE

Study Title: Caregiver Health

Target Population: No diagnosis; Mother of a child between 9 and 45 years old with schizophrenia.

Aim: To understand more about the relationship of caregiving to the physical health of mothers of individuals with schizophrenia.

Pamela Voss, MA
p-voss( at )northwestern.edu
312-503-5235
Michael Francis Fleming, MD, MPH

Study Title: SIMmersion Vocational Rehabilitation Study

Target Population: Adults 18 to 65 years old with Axis I diagnosis (depression, bipolar disorder, schizophrenia, post traumatic stress disorder, or autism spectrum disorder).

Aim: To determine whether the training package, including the simulated job interview, will lead to better job interview skills.

Tania Michaels, BS
tania.michaels( at )northwestern.edu
312-503-9095
Evan Goulding, MD, PhD

Study Title: Mobile Monitoring for Long-Term Behavioral Data Collection in Bipolar Disorder

Target Population: Adults 18 to 65 years old with Bipolar Disorder.

Aim:  To evaluate the use of mobile phones for collecting behavioral data to improve the ability to detect symptoms and improve treatment.

To learn more about this study, please visit our website at http://livewell.northwestern.edu/.

D. Barrett Share, MA
daniel.share1( at )northwestern.edu
312-503-0307
Herbert Meltzer, MD

Study Title: Takeda 301

Target Population: Adults 18 to 75 years old with an acute depressive episode.

Aim: To evaluate the efficacy of the study drug compared with placebo.

Marko Mihailovic MA, LPC, CCRC
marko.mihailovic( at )northwestern.edu
312-503-9096
John Csernansky MD

Study Title: Effects of Fanapt® (Iloperidone) on Social Cognitive Performance

Target Population: Adults 18 to 55 years old with psychosis (less than 5 years of treatment).

Aim: To examine whether initiating treatment with Fanapt is associated with improvement in performance on social-cognitive tasks.

Leah Drummond, BA
leah.drummond( at )northwestern.edu
312-503-4901
Herbert Meltzer, MD

Study Title: High Dose Lurasidone (HDL)

Target Population: Adults 18 to 60 years old with treatment-resistant psychosis.

Aim: To determine the efficacy of a high dose of Latuda for people diagnosed with treatment-resistant psychosis.

Ilse Salinas, BA
ilse.salinas( at )northwestern.edu
312-503-5460
Herbert Meltzer, MD

Study Title: Envivo 015 and 017

Target Population: Adults 18-50 years old with schizophrenia (in the stable phase). 

Aim: To investigate whetner the study drug is a potential treatment for cognitive impairment associated with schizophrenia and/or psychosis.

Marko Mihailovic MA, LPC, CCRC
marko.mihailovic( at )northwestern.edu
312-503-9096
Morris Goldman, MD

Study Title: Oxytocin Stress

Target Population: Adults 18 to 65 years old with psychosis.

Aim: To assess if intranasal oxytocin normalizes the enhanced responses to stress in patients with water imbalance.

Emily Ginger, BA
EmilyGinger( at )northwestern.edu
312-503-4901
James Reilly, PhD

Study Title:   GLYX-13

Target Population:  Healthy individuals and individuals with schizophrenia or schizoaffective from 18 to 40 years old.

Aim:  To investigate whether a novel medication can improve learning and memory in healthy adults and those with psychiatric illness

Jessica Berger, LCSW
jessica.berger1( at )northwestern.edu
312-503-4995
Lei Wang, PhD

Study Title: HippoPCI

Target Population: Female breast cancer patients between 50 to 65 years old.

Aim: To improve our understanding of differences in size, shape and activity of a variety of brain areas that can occur in women with breast cancer undergoing adjuvant chemotherapy or hormonal therapy, and how these brain areas are related to the development of mild cognitive impairment as a result  treatment.

Melody Fairchild MAT
m-fairchild( at )northwestern.edu
312-503-7071
Mehmet E. Dokucu, MD PhD

Study Title: Repetitive Transcranial Magnetic Stimulation (rTMS) in Breast Cancer Patients with Depression and Anxiety

Target Population: Female Breast Cancer Patients between 22 to 70 years old who are currently depressed.

Aim: To test the safety and tolerability of left- and right-sided rTMS as a treatment for depression and anxiety in breast cancer survivors. 

Pamela Voss, MA
p-voss( at )northwestern.edu
(312) 503-5235
Herbert Meltzer, MD

Study Title: Atlas

Target Population: Adults 18 to 65 years old with bipolar disorder.

Aim: To determine the efficacy of a long-acting injectable medication (Aripiprazole) for people diagnosed with bipolar disorder.
Stephanie Schuette
nwu-sas375( at )northwestern.edu
1-855-99-ASHER
Crystal Clark, MD, MSc

Study Title: Pharmacokinetics of Lamotrigine in Pregnant and Postpartum Women with Bipolar Disorder

Target Population: Pregnant Women ages 18-45 years old who are taking daily Lamotrigine (Lamictal) for Bipolar Disorder.

Aim: To assess the impact of the dynamic physiology of pregnancy on the L/D ratio and bioavailability of LTG in women with Bipolar Disorder.

Stephanie Schuette
nwu-sas375( at )northwestern.edu
312-695-6010 Ext. 56010
Suena H. Massey, MD

Study Title: Can Prenatal Oxytocin Concentration Predict Likelihood of Postpartum Depression?

An Opportunity for Early Intervention and Prevention in a Vulnerable Population.

Target Population: Pregnant Women ages 18 and older who are not currently receiving treatment for depression.

Aim: To determine the relationship between third trimester plasma oxytocin concentration and symptoms of postpartum depression

Andrea Roberts BA
andrea.roberts( at )northwestern.edu
312-503-5748
Hans Breiter, MD

Study Title: Chicago Adolescent Low-level Marijuana Use Study

Target population: Males age 18-19 who use marijuana recreationally or have never used marijuana.

Aim: To investigate the effects of adolescent marijuana use on brain function. 

Veronica Marin BA
Veronica.marin2( at )northwestern.edu
312-503-3460
Hans Breiter, MD

Study Title: Engineering-Based Behavior Science

Target Population: 18-40 year old healthy controls. (No family history of psychological illness)

Aim: To investigate human cognition and emotion in general with data collected from the brain with an engineering-based focus to form a mathematical framework for predicting behavior and pathology.